Objective: To investigate the impact of cervical cell abnormalities detected in the puerperium in association with HIV-1 infection on pregnancy outcomes.
| INTRODUCTION
In 2015 alone, an estimated 526 000 new cases of cervical cancer were reported globally, and in the same year, an estimated 239 000 women died from the disorder.
1 Cervical cancer is the leading cause of cancer-related death in women in most parts of Sub-Saharan Africa.
1
Persistent infection with a high-risk type of HPV is associated with the disease: of the 15 high-risk types, HPV-16 and HPV-18 account for 70% of cases of cervical cancer.
2
Cervical cytology and HPV testing are currently the most effective screening tools used in the prevention of cervical cancer. 3 Cervical cancer precursors can be detected by cervical cytology, commonly known as the Papanicolaou (Pap) test. Consistent evidence indicates that HIV-positive women have a higher prevalence of HPV infection, the infection is more persistent, and the prevalence of pre-invasive cervical lesions is higher 4 In 2014, cervical cancer was ranked in the top 10 causes of death among women in South Africa, which is also one of the four countries globally with the highest HIV prevalence in women of reproductive age. 5, 6 Moreover, there is growing evidence of a high prevalence of high-risk HPV infection and cervical intraepithelial neoplasia (CIN) 2/3 among HIV-infected women of reproductive age in South Africa.
7,8
Studies of cervical lesions in pregnancy are sparse, and the available studies report a low but a wide range of prevalences of cervical cancer (0.1-12 per 10 000 pregnancies) and CIN (0.13-0.27 per 10 000 pregnancies). 9, 10 There is no evidence that pregnancy itself increases the rate of CIN progression to invasive carcinoma.
11,12
Pregnancy outcomes have also been reported as unaltered by cervical cancer or CIN. 9 A multivariable analysis of more than 3000 women with a HPV prevalence of 10% concluded that HPV was not an independent risk factor for preterm delivery. 13 Many previous studies were conducted in settings with a low prevalence of HIV, and it is becoming increasingly evident that HIV-positive pregnant women are more likely to have a high prevalence of HPV and pre-invasive cervical lesions. 14, 15 Although HIV is independently associated with adverse pregnancy outcomes, to our knowledge, there are no studies that have evaluated pregnancy outcomes in women with HIV and HPV infection/CIN. 16 In the present study, we investigated the impact of cervical squamous cell abnormalities in association with HIV infection on pregnancy outcomes. 
| MATERIALS AND METHODS

| RESULTS
Of the 1480 pregnant women enrolled in the SAHAPs study, 564 In a separate bivariate analysis (Table 2) , birth outcomes were compared between women with and without cytological abnormalities. No marked differences in the prevalences of low birth weight and non-live births in these comparator groups were identified. Although the proportion of preterm births was higher among women with HGSILs as compared with women with LGSILs, ASCUS, or normal cytology, this association was not statistically significant (P=0.222).
In comparing the pregnancy outcomes among HIV-infected and HIV-uninfected women with a cytological abnormality, the rates of premature birth, low birth weight, and live birth were similar across all groups ( Table 3 ). The frequency of a low birth weight was, however, significantly higher among HIV-positive women with a normal cytological result when compared with their HIV-negative counterparts (P=0.026) ( Table 3) .
| DISCUSSION
A Pap smear routinely performed approximately 3 months after delivery revealed cervical squamous cell abnormalities in 8% of the study population. Notably, older women with one or more previous pregnancies were more likely to be diagnosed with HGSILs, whereas younger women were more likely to present with atypical squamous cell appearance or LGSILs. We can also confirm that HIV-1 infection was certainly related to LGSIL or HGSIL detected after delivery, with the prevalence of HGSILs among women with HIV comorbidity being less than 2%. We believe this is the first study to determine the effect of cervical lesions in combination with HIV infection on pregnancy outcomes. Although the presence of cervical lesions by itself has not previously been associated with poor birth outcomes, the underlying pathogenesis of HPV infection has been associated with preterm birth 9, 20 In the present study, where we expected HIV-positive women with
LGSILs or HGSILs to have worse pregnancy outcomes than HIVuninfected women with LGSILs or HGSILs, there was no evidence of this association and neither was this evident for LGSIL or HGSIL alone.
A limited number of studies of pregnant women reported the prevalence of CIN in pregnancy to range between 1% and 5%. findings from screening in pregnancy, whereas other studies-including the present study-have presented findings from screening in the postpartum period 23 However, there is evidence that noninvasive CIN diagnosed in pregnancy has a tendency not to progress during pregnancy, and 48%-70% of cases have regressed to complete remission after delivery. 
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